Accessibility Menu
 
Genetic Technologies logo

Genetic Technologies

(NASDAQ) GENE

Current PriceN/A
Market CapN/A
Since IPO (2005)-100%
5 Year-93%
1 Year-78%
1 Month-7%

Genetic Technologies Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$17.44M

Net Income (TTM)

$23.77M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

GENE: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Genetic Technologies

Industry

Life Sciences Tools and Services

Employees

58

CEO

Simon Morriss

Headquarters

Fitzroy, VIC 3065, AU

GENE Financials

Key Financial Metrics (TTM)

Gross Margin

51%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

-2%

Return on Capital

-6%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$3.90M

Operating Income

$12.21M

EBITDA

$11.43M

Operating Cash Flow

$9.68M

Capital Expenditure

$32.97K

Free Cash Flow

$9.71M

Cash & ST Invst.

$1.02M

Total Debt

$875.19K

Genetic Technologies Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2024YOY CHG

Revenue

$4.80M

-16.7%

Gross Profit

$2.80M

-27.9%

Gross Margin

58.25%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

55

N/A

Net Income

$5.60M

-72.3%

EBITDA

$5.30M

-47.8%

Quarterly Fundamentals

Name
Q4 2024YOY CHG

Net Cash

$145.42K

-98.7%

Accounts Receivable

$2.13M

-12.2%

Inventory

$206.47K

-48.1%

Long Term Debt

$22.92K

-94.1%

Short Term Debt

$852.26K

+222.7%

Return on Assets

-1.94%

N/A

Return on Invested Capital

-6.13%

N/A

Free Cash Flow

$5.67M

-259.1%

Operating Cash Flow

$5.67M

-277.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ICADiCAD, Inc.
$3.87+3.75%
GTHGenetron Holdings Limited
$4.03+0.12%
PROCProcaps Group S.A.
$1.01+100.00%
RVLPRVL Pharmaceuticals plc
$0.03-32.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$8.28-0.02%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.25-0.07%
TQQQProShares Trust - ProShares UltraPro Qqq
$41.23-0.07%
IBITiShares Bitcoin Trust
$38.82-0.03%

Questions About GENE

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.